DEMENTIA, FRONTOTEMPORAL
Clinical trials for DEMENTIA, FRONTOTEMPORAL explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA, FRONTOTEMPORAL trials appear
Sign up with your email to follow new studies for DEMENTIA, FRONTOTEMPORAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy infused directly into brain aims to halt rare dementia
Disease control Recruiting nowThis early-phase trial tests a gene therapy called AVB-101 for people with frontotemporal dementia caused by GRN gene mutations. The therapy delivers a working copy of the GRN gene directly into the brain during a one-time procedure. The study will enroll 18 adults aged 30-75 to …
Matched conditions: DEMENTIA, FRONTOTEMPORAL
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Bilingual brain boost: new therapy targets language loss in dementia
Symptom relief Recruiting nowThis study tests a speech therapy program for bilingual Spanish-English or Spanish-Catalan speakers with primary progressive aphasia, a condition that slowly damages language abilities. Sixty participants will receive personalized script training via video sessions, while 30 othe…
Matched conditions: DEMENTIA, FRONTOTEMPORAL
Phase: NA • Sponsor: Stephanie Grasso • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC